scholarly article | Q13442814 |
P2093 | author name string | C C Wilson | |
B E Palmer | |||
E Boritz | |||
N Blyveis | |||
P2860 | cites work | Pathogenesis of human immunodeficiency virus infection | Q24634681 |
Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia | Q28254584 | ||
Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression | Q31918166 | ||
Differential expression of interleukin-2 and gamma interferon in human immunodeficiency virus disease | Q33847162 | ||
Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution | Q33932773 | ||
High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation | Q33950164 | ||
Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease | Q34130886 | ||
Apoptotic cell death in the pathogenesis of infectious diseases. | Q34361975 | ||
Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro | Q34570241 | ||
Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging | Q34581195 | ||
Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals | Q36230977 | ||
CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection | Q36637922 | ||
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection | Q36889122 | ||
The role of HIV1 Nef in T-cell activation: Nef impairs induction of Th1 cytokines and interacts with the Src family tyrosine kinase Lck. | Q41338340 | ||
Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir | Q43508618 | ||
HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression | Q43750477 | ||
Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens. | Q43954731 | ||
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315. | Q44015315 | ||
Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin. | Q44558202 | ||
Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease | Q45740979 | ||
Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 Nef gene-induced expression. | Q45771524 | ||
Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation | Q45877028 | ||
Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects. | Q45940452 | ||
Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease. | Q52026668 | ||
Early T-helper cell defects in HIV infection. | Q52100356 | ||
Immune control of HIV-1 after early treatment of acute infection | Q56961920 | ||
Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans | Q59046097 | ||
Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease | Q61767238 | ||
Programmed death of T cells in HIV-1 infection | Q67518695 | ||
Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition | Q69383880 | ||
Selective CD4+ T cell deletion after specific activation in HIV-infected individuals; protection by anti-CD28 monoclonal antibodies | Q71233527 | ||
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor | Q72059554 | ||
Downregulation of CD28 surface antigen on CD4+ and CD8+ T lymphocytes during HIV-1 infection | Q72668437 | ||
Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response | Q73297445 | ||
Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease | Q73470103 | ||
CD28 costimulation and T lymphocyte proliferative responses in HIV-1 infection | Q73781386 | ||
CD40 ligand trimer and IL-12 enhance peripheral blood mononuclear cells and CD4+ T cell proliferation and production of IFN-gamma in response to p24 antigen in HIV-infected individuals: potential contribution of anergy to HIV-specific unresponsivene | Q74027299 | ||
CD40 ligand and IFN-gamma synergistically restore IL-12 production in HIV-infected patients | Q74375686 | ||
Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-1 infection | Q77324015 | ||
Lymphoproliferative response to HIV type 1 p24 in long-term survivors of HIV type 1 infection is predictive of persistent AIDS-free infection | Q78121234 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 5925-5936 | |
P577 | publication date | 2002-06-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4(+) T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication | |
P478 | volume | 76 |
Q33841127 | A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection |
Q36223710 | Advances in understanding immunologic control of HIV infection |
Q34267776 | Animal models for viral infection and cell exhaustion |
Q35923352 | Antigen-presenting cell modulation induces a memory response to p24 in peripheral blood leukocytes from human immunodeficiency virus-infected individuals |
Q41190952 | Association of KIR3DL1/S1 and HLA-Bw4 with CD4 T cell counts in HIV-infected Mexican mestizos |
Q35175897 | Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection |
Q90050621 | Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure |
Q45708636 | CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjects |
Q37327826 | CD4+ T cell targeting of human immunodeficiency virus type 1 (HIV-1) peptide sequences present in vivo during chronic, progressive HIV-1 disease |
Q39280285 | CD4+ T cells from HIV-1-infected patients recognize wild-type and mutant human immunodeficiency virus-1 protease epitopes |
Q34325840 | Cellular immune responses in asymptomatic human immunodeficiency virus type 1 (HIV-1) infection and effects of vaccination with recombinant envelope glycoprotein of HIV-1. |
Q44624338 | Cellular immune responses in human immunodeficiency virus (HIV)-1-infected children: is immune restoration by highly active anti-retroviral therapy comparable to non-progression? |
Q35784804 | Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load |
Q81366452 | Characterization of HIV-1 Gag-specific T cell responses in chronically infected Indian population |
Q37422520 | Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides |
Q37410726 | Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. |
Q36474240 | Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2 |
Q35140055 | Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons |
Q35784244 | Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infection |
Q52004956 | Evidence for Gag p24-specific CD4 T cells with reduced susceptibility to R5 HIV-1 infection in a UK cohort of HIV-exposed-seronegative subjects |
Q37288012 | Evidence for dendritic cell-dependent CD4(+) T helper-1 type responses to commensal bacteria in normal human intestinal lamina propria |
Q33942552 | Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response |
Q35864285 | Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity - The ANRS-EP38-IMMIP Study |
Q36371562 | HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity |
Q33731771 | HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound |
Q95847922 | HIV-Resistant and HIV-Specific CAR-Modified CD4+ T Cells Mitigate HIV Disease Progression and Confer CD4+ T Cell Help In Vivo |
Q37866624 | HIV-specific CD4 T cells and immune control of viral replication |
Q37051248 | HLA/KIR restraint of HIV: surviving the fittest |
Q36926499 | Host CCL3L1 gene copy number in relation to HIV-1-specific CD4+ and CD8+ T-cell responses and viral load in South African women |
Q45395724 | Human immunodeficiency virus (HIV)-specific T helper responses fail to predict CD4+ T cell decline following short-course treatment at primary HIV-1 infection |
Q37596842 | Human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levels |
Q37104112 | Immune recovery in HIV-infected patients after Candida esophagitis is impaired despite long-term antiretroviral therapy |
Q45411590 | Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses |
Q33427803 | Immunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection |
Q36989456 | Immunogenetics of HIV disease |
Q27477797 | Impaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV Coinfection |
Q34779237 | Impaired T-cell proliferation among HAART-treated adults with suboptimal CD4 recovery in an African cohort |
Q42427922 | In vivo blockade of the PD-1 receptor suppresses HIV-1 viral loads and improves CD4+ T cell levels in humanized mice |
Q39550595 | Interleukin-12p70 expression by dendritic cells of HIV-1-infected patients fails to stimulate gag-specific immune responses |
Q35956923 | Low antigen-specific CD4 T-cell immune responses despite normal absolute CD4 counts after long-term antiretroviral therapy an African cohort |
Q35153496 | Lymphocytic alveolitis is associated with the accumulation of functionally impaired HIV-specific T cells in the lung of antiretroviral therapy-naive subjects |
Q39991596 | Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection |
Q37374667 | Multiple T-cell responses to human immunodeficiency virus type 1 are enhanced by dendritic cells |
Q42043737 | Nonlinear observer output-feedback MPC treatment scheduling for HIV. |
Q42109893 | Progress in defining CD4 helper cell responses in chronic viral infections |
Q37700859 | Regulation of virus-specific CD4+ T cell function by multiple costimulatory receptors during chronic HIV infection |
Q34801866 | STI and beyond: the prospects of boosting anti-HIV immune responses |
Q74780517 | The Role of CD4(+) and CD8(+) T Cells in Controlling HIV Infection |
Search more.